Deciphera Pharmaceuticals Inc (DCPH)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

500 TOTTEN POND ROAD WALTHAM, MA 02451

Deciphera Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops kinase inhibitor treatments for various type of cancer diseases including gastrointestinal, stromal tumors, advance systemic mastocytosis, gliomas, and other solid tumors. Deciphera Pharmaceuticals serves patients globally.

Data based on most recent fiscal year report
Market Cap712.743 Million Shares Outstanding32.59 Million Avg Volume145.652 Thousand
1-Yr BETA vs S&P TR1.853 Current Ratio12.77 Quick Ratio12.77
View SEC Filings from DCPH instead.
Q2 2019 All Institutions Hedge Funds 1
To trade DCPH now:
Filers who had this stock in their top 10: 3 2 (0.21%)
13F Filers holding this stock: 83 17 (1.76%)
Aggregate 13F shares on 06/30/2019: 23.133 Million 15.756 Million
Aggregate 13F shares on 03/31/2019: 22.484 Million 15.539 Million
Percent change: 2.89% 1.40%
Funds creating new positions: 16 1
Funds Adding to an existing position: 35 8
Funds closing out their position: 11 7
Funds reducing their position: 17 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding DCPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

207 Thousand total shares from 15 transactions

Exercise Derivative Conversion (M)

182 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KELLY THOMAS PATRICK CHIEF FINANCIAL OFFICER

  • Officer
0 2019-08-13 8

TAYLOR MICHAEL DOUGLAS

  • Director
0 2019-08-13 5

BRISTOL JAMES ARTHUR

  • Director
0 2019-08-13 5

FLYNN DANIEL LEE CHIEF SCIENTIFIC OFFICER

  • Officer
146,549 2019-08-13 4

KELLEY SUSAN L.

  • Director
0 2019-07-08 2

RATCLIFFE LIAM

  • Director
0 2019-06-14 0

ALLEN PATRICIA L

  • Director
0 2019-06-11 1

ROSS MICHAEL JAY

  • Director
0 2019-06-11 1

WALSH DENNIS LEO

  • Director
0 2019-06-11 1

BENZ EDWARD J. JR

  • Director
0 2019-06-11 1

MARTIN JOHN RICHARD

  • Director
0 2019-06-11 1

HOERTER STEVEN L.

  • Director
0 2019-06-06 1

MARTIN DANIEL C. CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-01-30 3

RUDDY STEPHEN B. CHIEF TECHNICAL OFFICER

  • Officer
0 2019-01-30 1

MORL CHRISTOPHER JOHN CHIEF BUSINESS OFFICER

  • Officer
0 2019-01-30 1

NEW LEAF VENTURE MANAGEMENT III, L.L.C.

NEW LEAF VENTURE ASSOCIATES III, L.P.

NEW LEAF VENTURES III, L.P.

NEW LEAF BIOPHARMA OPPORTUNITIES I, L.P.

NEW LEAF BPO ASSOCIATES I, L.P.

  • 10% Owner
No longer subject to file 2018-06-25 0

BRIGHTSTAR ASSOCIATES LLC

  • 10% Owner
16,572,370 2017-10-02 0

ROSEN OLIVER CHIEF MEDICAL OFFICER

  • Officer
0 2017-10-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER

2019-08-13 S 29,712 $41.33 d 24,500 146,549.00 direct yes

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2019-08-13 M 11,250 d 138,008 0.00 direct

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2019-08-13 S 7,264 $40.69 d 3,986 0.00 direct yes

TAYLOR MICHAEL DOUGLAS - Director

2019-08-13 S 4,000 $42.49 d 0 0.00 direct yes

TAYLOR MICHAEL DOUGLAS - Director

2019-08-13 S 3,433 $39.47 d 19,067 0.00 direct yes

BRISTOL JAMES ARTHUR - Director

2019-08-13 S 100 $42.90 d 0 0.00 direct yes

BRISTOL JAMES ARTHUR - Director

2019-08-13 S 11,513 $39.24 d 13,487 0.00 direct yes

FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER

2019-08-13 M 123,107 d 349,571 146,549.00 direct

FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER

2019-08-13 S 93,395 $40.26 d 54,212 146,549.00 direct yes

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2019-08-13 S 400 $42.92 d 0 0.00 direct yes

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2019-08-13 M 11,250 $1.89 a 11,250 0.00 direct

TAYLOR MICHAEL DOUGLAS - Director

2019-08-13 S 1,300 $41.77 d 4,000 0.00 direct yes

TAYLOR MICHAEL DOUGLAS - Director

2019-08-13 M 22,500 $1.89 a 22,500 0.00 direct

BRISTOL JAMES ARTHUR - Director

2019-08-13 S 700 $42.05 d 100 0.00 direct yes

BRISTOL JAMES ARTHUR - Director

2019-08-13 M 25,000 $1.89 a 25,000 0.00 direct

FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER by daniel l. flynn irrevocable trust

2019-08-13 S 25,000 $42.90 d 66,779 146,549.00 indirect yes

FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER

2019-08-13 M 123,107 $1.89 a 147,607 146,549.00 direct

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2019-08-13 S 3,586 $42.25 d 400 0.00 direct yes

TAYLOR MICHAEL DOUGLAS - Director

2019-08-13 M 22,500 d 517,135 0.00 direct

TAYLOR MICHAEL DOUGLAS - Director

2019-08-13 S 13,767 $40.50 d 5,300 0.00 direct yes

BRISTOL JAMES ARTHUR - Director

2019-08-13 M 25,000 d 88,408 0.00 direct

BRISTOL JAMES ARTHUR - Director

2019-08-13 S 12,687 $40.50 d 800 0.00 direct yes

KELLEY SUSAN L. - Director

2019-07-08 A 24,000 a 24,000 0.00 direct

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2019-06-19 M 177 $1.89 a 177 0.00 direct

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2019-06-19 M 177 d 149,258 0.00 direct

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2019-06-19 S 177 $25.00 d 0 0.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments